#Ipsen's #Ojemda is on course to become the first targeted medicine in the #EU for some #children with a form of #braincancer known as #lowgradeglioma, after it was recommended for approval by the #EMA's human medicines committee. #CHMP

pharmaphorum.com/news/chmp-ba...

Tovorafenib (Ojemda): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Tovorafenib (Ojemda) is a precision cancer therapy known as a pan-RAF inhibitor. This article is about its uses in cancer, side effects, dosage.

Tovorafenib (Ojemda): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/tovora...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Tovorafenib #Ojemda #BrainTumors #Glioma #FDAApproval